Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.

Jabbour, Salma K; Lee, Ki Hyeong; Frost, Nikolaj; Breder, Valeriy; Kowalski, Dariusz M; Pollock, Theodore; Levchenko, Evgeny; Reguart, Noemi; Martinez-Marti, Alex; Houghton, Baerin; Paoli, Jean-Baptiste; Safina, Sufia; Park, Keunchil; Komiya, Takefumi; Sanford, Amy; Boolell, Vishal; Liu, Hong; Samkari, Ayman; Keller, Steven M; Reck, Martin

Jabbour, Salma K; Lee, Ki Hyeong; Frost, Nikolaj; Breder, Valeriy; Kowalski, Dariusz M; Pollock, Theodore; Levchenko, Evgeny; Reguart, Noemi; Martinez-Marti, Alex; Houghton, Baerin; Paoli, Jean-Baptiste; Safina, Sufia; Park, Keunchil; Komiya, Takefumi; Sanford, Amy; Boolell, Vishal; Liu, Hong; Samkari, Ayman; Keller, Steven M; Reck, Martin.

Afiliação

Jabbour SK; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick.
Lee KH; Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, South Korea.
Frost N; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Breder V; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.
Kowalski DM; The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Pollock T; Northeastern Health System, Tahlequah, Oklahoma.
Levchenko E; N.N. Petrov National Medical Research Center of Oncology, St Petersburg, Russia.
Reguart N; Thoracic Oncology Unit, Department of Medical Oncology, IDIBAPS, Hospital Clínic, Barcelona, Spain.
Martinez-Marti A; Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Houghton B; Mid North Coast Cancer Institute, Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia.
Paoli JB; Radiotherapie, Clinique Clairval, Marseille, France.
Safina S; Medical Oncology, Republican Dispensary of Tatarstan Ministry of Healthcare, Kazan, Russia.
Park K; Division of Hematology/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Komiya T; Hematology/Medical Oncology, Parkview Cancer Institute, Fort Wayne, Indiana.
Sanford A; Sanford Health, Sioux Falls, South Dakota.
Boolell V; Ballarat Health Services, Ballarat, Victoria, Australia.
Liu H; Merck & Co, Inc, Kenilworth, New Jersey.
Samkari A; Merck & Co, Inc, Kenilworth, New Jersey.
Keller SM; Merck & Co, Inc, Kenilworth, New Jersey.
Reck M; LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.

JAMA Oncol ; 2021 Jun 04.

Article em En | MEDLINE | ID: mdl-34086039

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google